(Reuters) -AbbVie has obtained the option to license a new blood cancer drug candidate from Simcere Pharmaceutical's unit for ...

The NHL has some of the most historic and unique logos in the entire world of sports. With the Seattle Kraken now in the fold, we can rank 32 logos around the league. There are many great logos ...

This post will discuss the top 10 famous logo designers and their iconic work. From Paul Rand's IBM logo to Michael Bierut's Mastercard. Logos are one of the most vital parts of a brand's identity. A ...

Alvotech (ALVO), a commercial-stage global biotech company specializing in the development and manufacture of biosimilar medicines, ...

Objectives To investigate the possibility of discontinuing adalimumab (ADA) for 1 year without flaring (DAS28-erythrocyte sedimentation rate (ESR) ≥3.2), and to identify factors enabling established ...

As a pharmacist working in the pharmacy benefit management (PBM) industry, I've witnessed firsthand the transformative impact of biologic drugs, like Humira. (That's the brand name for the version ...

AbbVie’s blockbuster Humira held 105 patents, shielding the anti-inflammatory drug from biosimilar competition for more than 20 years. Proposed reforms could help prevent companies from extending ...

A dose de-escalation program targeting Humira (adalimumab) and Stelara (ustekinumab) saved more than $86,000 per successful intervention, according to research findings presented today at the American ...